Recombinant FVII in orthotopic liver transplantation (OLT): a preliminary single centre experience

被引：10

作者：

De Gasperi, A

Baudo, F

De Carlis, L

机构：

[1] Osped Niguarda Ca Granda, Serv Anestesia 2, I-20163 Milan, Italy

[2] Osped Niguarda Ca Granda, I-20163 Milan, Italy

[3] Osped Niguarda Ca Granda, I-20163 Milan, Italy

来源：

INTENSIVE CARE MEDICINE | 2005年 / 31卷 / 02期

关键词：

D O I：

10.1007/s00134-004-2525-9

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：315 / 316

页数：2

共 5 条

[1] Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation - A pilot study [J].

Hendriks, HGD ;

Meijer, K ;

de Wolf, JTM ;

Klompmaker, IJ ;

Porte, RJ ;

de Kam, PJ ;

Hagenaars, AJM ;

Melsen, T ;

Slooff, MJH ;

van der Meer, J .

TRANSPLANTATION, 2001, 71 (03) :402-405

[2] Coagulopathies in hepatic disease [J].

Kang, Y .

LIVER TRANSPLANTATION, 2000, 6 (04) :S72-S75

[3] Recombinant FVIIa for intractable hemorrhage: more questions than answers [J].

Key, NS .

TRANSFUSION, 2003, 43 (12) :1649-1651

[4]

PLASINICH R, 2002, HEPATOLOGY, V36, P660

[5] Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study [J].

Porte, RJ ;

Molenaar, IQ ;

Begliomini, B ;

Groenland, THN ;

Januszkiewicz, A ;

Lindgren, L ;

Palareti, G ;

Hermans, J ;

Terpstra, OT .

LANCET, 2000, 355 (9212) :1303-1309

← 1 →